KR20050121196A - 심혈관 질환의 치료를 위한 ｌ―카르니틴의 용도 - Google Patents

심혈관 질환의 치료를 위한 ｌ―카르니틴의 용도 Download PDF

Info

Publication number
KR20050121196A
KR20050121196A KR1020057013711A KR20057013711A KR20050121196A KR 20050121196 A KR20050121196 A KR 20050121196A KR 1020057013711 A KR1020057013711 A KR 1020057013711A KR 20057013711 A KR20057013711 A KR 20057013711A KR 20050121196 A KR20050121196 A KR 20050121196A
Authority
KR
South Korea
Prior art keywords
carnitine
use according
myocardial infarction
acute myocardial
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020057013711A
Other languages
English (en)
Korean (ko)
Inventor
알레르도 코베르크
Original Assignee
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Publication of KR20050121196A publication Critical patent/KR20050121196A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020057013711A 2003-04-17 2004-03-03 심혈관 질환의 치료를 위한 ｌ―카르니틴의 용도 Ceased KR20050121196A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2003A000178 2003-04-17
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.

Publications (1)

Publication Number Publication Date
KR20050121196A true KR20050121196A (ko) 2005-12-26

Family

ID=29765768

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057013711A Ceased KR20050121196A (ko) 2003-04-17 2004-03-03 심혈관 질환의 치료를 위한 ｌ―카르니틴의 용도

Country Status (11)

Country Link
US (1) US20060052450A1 (enExample)
EP (1) EP1613301A1 (enExample)
JP (1) JP2006523685A (enExample)
KR (1) KR20050121196A (enExample)
CN (2) CN101467992A (enExample)
AU (2) AU2004229256A1 (enExample)
BR (1) BRPI0406552A (enExample)
CA (1) CA2508636A1 (enExample)
IT (1) ITRM20030178A1 (enExample)
MX (1) MXPA05007612A (enExample)
WO (1) WO2004091602A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20070260674A1 (en) * 2006-05-02 2007-11-08 Research In Motion Limited Push framework for delivery of dynamic mobile content
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
EP2353596A1 (en) 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2012150146A1 (en) 2011-05-03 2012-11-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition useful for the treatment of lipid metabolism disorders
CN114073705A (zh) * 2020-08-14 2022-02-22 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS531812B2 (enExample) * 1972-12-07 1978-01-23
WO2000030637A1 (en) * 1998-11-26 2000-06-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia

Also Published As

Publication number Publication date
CA2508636A1 (en) 2004-10-28
EP1613301A1 (en) 2006-01-11
ITRM20030178A0 (it) 2003-04-17
AU2010202396A1 (en) 2010-07-01
ITRM20030178A1 (it) 2004-10-18
MXPA05007612A (es) 2005-09-30
US20060052450A1 (en) 2006-03-09
AU2004229256A1 (en) 2004-10-28
CN1717232A (zh) 2006-01-04
WO2004091602A1 (en) 2004-10-28
JP2006523685A (ja) 2006-10-19
BRPI0406552A (pt) 2005-12-20
CN101467992A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
AU2010202396A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
US6881739B1 (en) Use of cortisol antagonists in the treatment of heart failure
KR101296479B1 (ko) 심혈관 질환 치료를 위한 ｌ-카르니틴 및 글루코오스의용도
HK1113542B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
HK1166003B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
US20090042983A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
HK40044975A (en) Joint use of compound a and compound b in preparation of medications for treatment of gout or hyperuricemia
HK1085929A (en) Use of l-carnitine for the treatment of cardiovascular diseases
CN1433302A (zh) 氢化可的松拮抗剂在治疗心力衰竭中的应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050725

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20090211

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110211

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20120501

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20111020

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20110211

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I